Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Improving the function of the kidney graft by verapamil– does it depend on metabolic or haemodynamic effect?

M Nowacki, M Droździk, K Ciechanowski, L Domański, K Safranof, Z Zietek, J Sienko, M Romanowski, T Sulikowski, M Kaminski, K Pabisiak, M Ostrowski

Ann Transplant 2009; 14(1): 58-58 :: ID: 880412

Abstract

The aim of this study was to evaluate influence of Verapamil on the function of the transplanted kidney three months after transplantation and influence of changing vessel resistance by Verapamil on the functioning transplanted kidney.
Material/Methods: 48 cadaver kidney donors and 96 transplanted patients. The analysed group was 48 kidneys that received injection of 100 μg of Verapamil directly into renal artery 2 minutes before beginning perfusion. The control group was 48 kidneys from the same pair without pre-conditioning with Verapamil.
Results: The level of kidneys' perfusion after adding Verapamil was significantly higher comparing to perfusion of kidneys without adding Verapamil (SD 161 ml/min vs. 111 ml/min). Recipients from the group, that received kidneys after adding Verapamil reached faster the level of 2.0 mg/dL of serum creatinine than recipients from the control group (p<0.005). Level of perfusion did not influence reaching 2.0 mg/dL serum creatinine level in both groups of recipients (p<0.05)
Conclusions: We noticed that Verapamil improves the kidney graft function in the first three months after transplantation. Verapamil reduces kidney's vessel resistance but it does not correlate with improving the function of the kidney after transplantation, however this effect could depend on metabolic effect [blocking calcium channels].

Keywords: Ischemia reperfusion injury, Kidney Transplantation, Organ Perfusion

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358